Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	6.02	108.13	101.99
Graham Fair Price	-66.65	16.38	49.13
PEG	5770.48	-0.16	< 0.005
Price/Book	-8.06	0.83	0.91
Price/Cash Flow	8.08	53.65	49.64
Prices/Earnings	736.74	17.55	-2.10
Price/Sales	-20.94	12.90	16.31
Price/FCF	8.08	53.65	49.64
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-8.44	0.49	0.54
Operating Margin	-20.77	0.33	0.42
ROA	-88.92	< 0.005	-0.03
ROE	-0.11	0.01	-89.01
ROIC	< 0.005	< 0.005	1.33
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	51.27	-99.98
Dividends QOQ	4.54	-1.00	-77.96
EBIT QOQ	-0.19	-0.07	60.76
EPS QOQ	-7.80	1.11	-85.75
FCF QOQ	0.83	-0.14	-82.56
Revenue QOQ	< 0.005	0.17	1725.21
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	269.65	216.17	-19.83
Days Sales Outstanding (DSO)	83.62	39.00	-53.36
Inventory Turnover	0.33	0.42	24.74
Debt/Capitalization	0.63	0.62	-0.60
Quick Ratio	0.53	0.65	23.85
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	31.53	31.72	0.61
Cash	1.69	3.01	77.84
Capex	-0.01	-0.04	-213.40
Free Cash Flow	0.57	0.49	-14.41
Revenue	1.75	2.05	17.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.34	1.54	15.41
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	65.76	71.33	8.48
Naive Interpretation	Member

06 - Financial Health · Weak

Rating